Market Cap 518.16M
Revenue (ttm) 0.00
Net Income (ttm) -57.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,806,300
Avg Vol 1,923,814
Day's Range N/A - N/A
Shares Out 104.89M
Stochastic %K 3%
Beta 0.46
Analysts Strong Sell
Price Target $12.67

Company Profile

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessiv...

Industry: Biotechnology
Sector: Healthcare
Phone: 786 629 1376
Address:
2222 Ponce de Leon Blvd., Floor 3, Coral Gables, United States
teaman60
teaman60 Aug. 7 at 11:16 AM
$RLMD I was right
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 6 at 10:04 PM
$RLMD Q2 '26 Earnings Results & Recap Reported GAAP EPS of -$0.11 up 63.33% YoY
0 · Reply
EarningsInsider
EarningsInsider Aug. 6 at 9:22 PM
https://www.marketbeat.com/earnings/reports/2026-8-6-relmada-therapeutics-inc-stock/ $RLMD Relmada Therapeutics Earnings Transcript
0 · Reply
teaman60
teaman60 Aug. 5 at 1:59 AM
$RLMD Well we have passed the time when they said test results would be released so I am not expecting good news on this.
1 · Reply
Lane0507
Lane0507 Aug. 4 at 10:49 PM
$RLMD A sleeper ready to bounce
0 · Reply
Quantumup
Quantumup Jul. 31 at 12:21 PM
$NBIX Baird-OP⬆️$225 was$186 Stifel-Buy⬆️$215 was$188 SLNO $RYTM $RLMD HRMY Needham-Buy⬆️$204 was$200~continue2see meaningful NBIX upside—driven by an established Ingrezza franchise—2 add'l growth products—well funded pipeline—w/ multiple data readouts '27+ Guggenheim-Buy⬆️$222 was $200; Here's what Guggenheim had to say in its note to investors: https://x.com/Quantumup1/status/2083165891739390434?s=20
0 · Reply
focafoca99
focafoca99 Jul. 28 at 12:47 PM
$RLMD installed Bipin Dalmia, PhD, MBA as its new chief business officer.
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 22 at 1:52 PM
$RLMD $5.11 Is the 200 major support I expect a bounce 🚨🚨
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 22 at 1:40 PM
$RLMD Adds!! No reason for this to be this low imo... $5.50 Possible next🔋🔋
0 · Reply
VikaDelic
VikaDelic Jul. 21 at 2:44 PM
$RLMD bottom is close, adding some back
0 · Reply
Latest News on RLMD
Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)

2026-08-06T21:35:46.000Z - 4 days ago

Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)


Relmada Therapeutics Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 4 days ago

Relmada Therapeutics Earnings Call Transcript: Q2 2026


Relmada Therapeutics Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 4 days ago

Relmada Therapeutics Quarterly report: Q2 2026


Relmada Therapeutics Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 4 days ago

Relmada Therapeutics Earnings release: Q2 2026


Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes

2026-06-29T11:10:10.000Z - 6 weeks ago

Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes


Relmada Therapeutics initiated with a Buy at H.C. Wainwright

2026-06-18T10:07:12.000Z - 7 weeks ago

Relmada Therapeutics initiated with a Buy at H.C. Wainwright


Relmada Therapeutics Slides: Corporate presentation

Jun 9, 2026, 7:00 AM EDT - 2 months ago

Relmada Therapeutics Slides: Corporate presentation


Relmada Therapeutics Transcript: AGM 2026

May 27, 2026, 9:30 AM EDT - 2 months ago

Relmada Therapeutics Transcript: AGM 2026


Relmada Therapeutics files automatic mixed securities shelf

2026-05-13T21:24:00.000Z - 3 months ago

Relmada Therapeutics files automatic mixed securities shelf


Relmada Therapeutics Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Relmada Therapeutics Earnings Call Transcript: Q1 2026


Relmada Therapeutics Quarterly report: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Relmada Therapeutics Quarterly report: Q1 2026


Relmada Therapeutics Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Relmada Therapeutics Earnings release: Q1 2026


Relmada Therapeutics Slides: Company presentation

May 12, 2026, 7:00 AM EDT - 3 months ago

Relmada Therapeutics Slides: Company presentation


Relmada Therapeutics Slides: Corporate presentation

May 12, 2026, 7:00 AM EDT - 3 months ago

Relmada Therapeutics Slides: Corporate presentation


Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026

May 5, 2026, 7:00 AM EDT - 3 months ago

Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026


Relmada Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Relmada Therapeutics Proxy statement: Proxy filing


Relmada Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Relmada Therapeutics Proxy statement: Proxy filing


Relmada Therapeutics Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Relmada Therapeutics Proxy statement: Proxy filing


Relmada Therapeutics Slides: Corporate presentation

Mar 30, 2026, 7:00 AM EDT - 4 months ago

Relmada Therapeutics Slides: Corporate presentation


Relmada Therapeutics Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Relmada Therapeutics Earnings Call Transcript: Q4 2025


Relmada Therapeutics Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Relmada Therapeutics Annual report: Q4 2025


Relmada Therapeutics Earnings release: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Relmada Therapeutics Earnings release: Q4 2025


Relmada Therapeutics Slides: Study Result Presentation

Mar 19, 2026, 7:00 AM EDT - 5 months ago

Relmada Therapeutics Slides: Study Result Presentation


Relmada Therapeutics Slides: Corporate presentation

Mar 19, 2026, 7:00 AM EDT - 5 months ago

Relmada Therapeutics Slides: Corporate presentation


Why Is Relmada Therapeutics Stock (RLMD) Up Today?

2026-03-09T12:00:38.000Z - 5 months ago

Why Is Relmada Therapeutics Stock (RLMD) Up Today?


Relmada Therapeutics initiated with a Buy at Lucid Capital

2026-03-02T11:38:48.000Z - 5 months ago

Relmada Therapeutics initiated with a Buy at Lucid Capital


Relmada Therapeutics initiated with a Buy at Jefferies

2025-12-22T00:10:11.000Z - 8 months ago

Relmada Therapeutics initiated with a Buy at Jefferies


Relmada Therapeutics Slides: Investor presentation

Nov 14, 2025, 6:00 AM EST - 9 months ago

Relmada Therapeutics Slides: Investor presentation


Relmada Therapeutics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Relmada Therapeutics Earnings Call Transcript: Q3 2025


Relmada Therapeutics Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Relmada Therapeutics Earnings release: Q3 2025


Relmada Therapeutics Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Relmada Therapeutics Quarterly report: Q3 2025


Relmada Therapeutics Transcript: Small-Cap Virtual Conference

Sep 18, 2025, 10:00 AM EDT - 11 months ago

Relmada Therapeutics Transcript: Small-Cap Virtual Conference


Relmada Issues Mid-Year CEO Letter to Shareholders

Sep 10, 2025, 7:15 AM EDT - 11 months ago

Relmada Issues Mid-Year CEO Letter to Shareholders


Relmada Therapeutics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Earnings Call Transcript: Q2 2025


Relmada Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Quarterly report: Q2 2025


Relmada Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Earnings release: Q2 2025


Relmada Therapeutics Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Earnings Call Transcript: Q1 2025


Relmada Therapeutics Earnings release: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Earnings release: Q1 2025


Relmada Therapeutics Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Quarterly report: Q1 2025


Relmada Therapeutics Transcript: Status Update

Apr 28, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Transcript: Status Update


Relmada Therapeutics Press release: Status Update

Apr 28, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Press release: Status Update


Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data


Relmada Therapeutics To Present NDV-01 Data at AUA2025

Apr 14, 2025, 7:30 AM EDT - 1 year ago

Relmada Therapeutics To Present NDV-01 Data at AUA2025


Relmada Therapeutics Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Relmada Therapeutics Proxy statement: Proxy Filing


Relmada Therapeutics Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Relmada Therapeutics Proxy statement: Proxy Filing


Relmada Therapeutics Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Earnings Call Transcript: Q4 2024


Relmada Therapeutics Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Annual report: Q4 2024


Relmada Therapeutics Earnings release: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Earnings release: Q4 2024


Relmada Therapeutics Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Relmada Therapeutics Earnings Call Transcript: Q3 2024


Relmada Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Relmada Therapeutics Quarterly report: Q3 2024


Relmada Therapeutics Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Relmada Therapeutics Earnings Call Transcript: Q2 2024


Relmada Therapeutics Quarterly report: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Relmada Therapeutics Quarterly report: Q2 2024


Relmada Therapeutics Earnings release: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Relmada Therapeutics Earnings release: Q2 2024


teaman60
teaman60 Aug. 7 at 11:16 AM
$RLMD I was right
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 6 at 10:04 PM
$RLMD Q2 '26 Earnings Results & Recap Reported GAAP EPS of -$0.11 up 63.33% YoY
0 · Reply
EarningsInsider
EarningsInsider Aug. 6 at 9:22 PM
https://www.marketbeat.com/earnings/reports/2026-8-6-relmada-therapeutics-inc-stock/ $RLMD Relmada Therapeutics Earnings Transcript
0 · Reply
teaman60
teaman60 Aug. 5 at 1:59 AM
$RLMD Well we have passed the time when they said test results would be released so I am not expecting good news on this.
1 · Reply
Lane0507
Lane0507 Aug. 4 at 10:49 PM
$RLMD A sleeper ready to bounce
0 · Reply
Quantumup
Quantumup Jul. 31 at 12:21 PM
$NBIX Baird-OP⬆️$225 was$186 Stifel-Buy⬆️$215 was$188 SLNO $RYTM $RLMD HRMY Needham-Buy⬆️$204 was$200~continue2see meaningful NBIX upside—driven by an established Ingrezza franchise—2 add'l growth products—well funded pipeline—w/ multiple data readouts '27+ Guggenheim-Buy⬆️$222 was $200; Here's what Guggenheim had to say in its note to investors: https://x.com/Quantumup1/status/2083165891739390434?s=20
0 · Reply
focafoca99
focafoca99 Jul. 28 at 12:47 PM
$RLMD installed Bipin Dalmia, PhD, MBA as its new chief business officer.
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 22 at 1:52 PM
$RLMD $5.11 Is the 200 major support I expect a bounce 🚨🚨
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 22 at 1:40 PM
$RLMD Adds!! No reason for this to be this low imo... $5.50 Possible next🔋🔋
0 · Reply
VikaDelic
VikaDelic Jul. 21 at 2:44 PM
$RLMD bottom is close, adding some back
0 · Reply
metalcook
metalcook Jul. 21 at 11:36 AM
$RLMD any catalysts coming up or desert storm?
0 · Reply
SannieVerraderlijk
SannieVerraderlijk Jul. 16 at 4:41 PM
$RLMD Added here
1 · Reply
Doozio
Doozio Jun. 27 at 3:25 PM
$RLMD it’s only obvious wen it’s obvious ENTA 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Jun. 27 at 3:24 PM
$RLMD da 🐑 are SKWD again as da rotation ONTA semis ENTA biotechs out of the tightness 🐒🍌🧠⏰♾️
0 · Reply
SannieVerraderlijk
SannieVerraderlijk Jun. 19 at 5:58 AM
$ABOS $CCCC $NKTR $RLMD $ SABS $ ZURA Some longs added to Russell 3000 yesterday
0 · Reply
Eathapoo
Eathapoo Jun. 16 at 5:05 PM
$VTGN hoping for the best here. I made the mistake selling $RLMD for $0.60 and then 💥. Holding strong. Let go $5.
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 10 at 1:48 PM
$RLMD $6.56 Broke.. $6.80 Next major resistance... Who loves June 🥇🥇
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 10 at 1:39 PM
$RLMD Another overnight swing winner 🥇🥇. $6.56 Still possible imo🚨🚨
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 10 at 11:46 AM
$RLMD $RLMD adds! $6.56 Next major resistance 🚨 🚨
0 · Reply
teaman60
teaman60 Jun. 2 at 4:53 PM
$RLMD Looks like maybe some bad test results have leaked
2 · Reply
ThaDankles
ThaDankles May. 22 at 10:13 PM
$RLMD $VTGN will be bigger than RLMD and more explosive. 1/3 the float and if phase 3 is positive then we have the only rapid a response non habit forming anti anxiety drug on the market…. Cmon a nasal spray. Hell I’d want a script for that! Huge market for that! 50$ on commercialization if it makes it that far before a buy out.
1 · Reply